Please use this identifier to cite or link to this item:
|Title:||Durable complete response after discontinuation of pembrolizumab in patients with metastatic melanoma|
Diede, Scott J
Gangadhar, Tara C.
Hodi, F. Stephen
Joseph, Richard W.
Joshua, Anthony M.
Wolchok, Jedd D.
Northern Clinical School: Surgery
|Publisher:||American Society of Clinical Oncology|
|Citation:||Durable complete response after discontinuation of pembrolizumab in patients with metastatic melanoma, Journal of Clinical Oncology, vol.36, 17, 2018,pp 1668-1674|
|Department/Unit/Centre:||Northern Clinical School: Surgery|
|Disclaimer:||This work has been made available to the staff and students of the University of Sydney for the purposes of research and study only. It constitutes material that is held by the University for the purposes of reporting for HERDC and the ERA. This work may not be downloaded, copied and distributed to any third party .|
|Type:||C1 - Refereed Journal articles|
|Appears in Collections:||University of Sydney Research Outputs|
Items in Sydney Research Online are protected by copyright, with all rights reserved, unless otherwise indicated.